beMedTech notes that as of tomorrow, 1 September, tele-expertise in dermatology is structurally reimbursed by RIZIV-INAMI.
Public source
Publisher name
Public post
In three out of four tele-expertise cases, the recommendation was that a consultation with a dermatologist was no longer needed. This was the outcome of 694 tele-experti…
Company
beMedTech
Belgian federation of medical technologies | Adding value to healthcare through medical technology
- Industry
- Medical Equipment Manufacturing
- Location
- Strombeek-Bever, BE
- Company size
- 11–50 employees
About beMedTech
beMedTech unites the manufacturers and distributors of medical devices in Belgium. By using medical technology, we help improve the quality of care for patients and support healthcare providers in their work. That's how we add value to healthcare.
See moreLatest activity
Latest activity from beMedTech
8 signals
Products & Services
beMedTech co-created the approach for Heart Center Aalst and Powerful Medical with AZORG as the first site to implement AI-supported clinical decision support for heart attack patients.
Presence & Recognition
beMedTech Managing Director Sabrina Suetens was invited to join the launch of Joachim De Vos' new book at the CEO Innovation Night in Brussels.
Presence & Recognition
beMedTech reached 11,000 followers on LinkedIn
Discover more
Similar signals
Similar public activity from other companies.
Legal & Regulatory
Omnidoc
Omnidoc contributed to the Belgian recognition of telemedicine in dermatology in the first September 2026.
Research & Knowledge
MedTech Europe
MedTech Europe and Mecomed published a new joint paper highlighting the implications of the EU MDR and IVDR transition and outlining key recommendations to support patient access and continuity of supply.
Research & Knowledge
ICT&health
ICT&health published an article in its magazine discussing digitalization in dermatology and the impact of smartphones on clinical scores.
Research & Knowledge
FibriCheck
FibriCheck published a whitepaper detailing the advantages of FibriCheck for Belgian health insurers.
Research & Knowledge
Nefemed